{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:56:52Z","timestamp":1784516212869,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11739-020-02523-9","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:03:16Z","timestamp":1603274596000},"page":"883-893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study"],"prefix":"10.1007","volume":"16","author":[{"given":"Ashkan","family":"Yahyavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Hemmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Derakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Banivaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Karimi Behnagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozhin","family":"Tofighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"TehraniYazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-4705","authenticated-orcid":false,"given":"Ali","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"2523_CR1","unstructured":"World Health Organization (2020) Coronavirus disease (COVID-19): weekly epidemiological update. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200921-weekly-epi-update-6.pdf?sfvrsn=d9cf9496_6. Accessed 22 Sept 2020"},{"issue":"10223","key":"2523_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/s0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (Lond Engl) 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/s0140-6736(20)30183-5","journal-title":"Lancet (Lond Engl)"},{"issue":"11","key":"2523_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan China. JAMA 323(11):1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"JAMA"},{"issue":"3","key":"2523_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"G Li","year":"2020","unstructured":"Li G, De Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discovery 19(3):149\u2013150. https:\/\/doi.org\/10.1038\/d41573-020-00016-0","journal-title":"Nat Rev Drug Discovery"},{"key":"2523_CR5","doi-asserted-by":"publisher","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV (2020) Renin-angiotensin-aldosterone system inhibitors in patients with covid-19. N Engl J Med 382 (17):1653\u20131659. https:\/\/doi.org\/10.1056\/NEJMsr2005760","DOI":"10.1056\/NEJMsr2005760"},{"issue":"3","key":"2523_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","volume":"63","author":"X Xu","year":"2020","unstructured":"Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63(3):457\u2013460. https:\/\/doi.org\/10.1007\/s11427-020-1637-5","journal-title":"Sci China Life Sci"},{"issue":"5742","key":"2523_CR7","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","volume":"309","author":"F Li","year":"2005","unstructured":"Li F, Li W, Farzan M, Harrison SC (2005) Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Sci (New York, NY) 309(5742):1864\u20131868. https:\/\/doi.org\/10.1126\/science.1116480","journal-title":"Sci (New York, NY)"},{"issue":"4","key":"2523_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586\u2013590. https:\/\/doi.org\/10.1007\/s00134-020-05985-9","journal-title":"Intensive Care Med"},{"issue":"3","key":"2523_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3760\/cma.j.issn.1001-0939.2020.03.016","volume":"43","author":"ML Sun","year":"2020","unstructured":"Sun ML, Yang JM, Sun YP, Su GH (2020) [Inhibitors of RAS might be a good choice for the therapy of COVID-19 Pneumonia]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi. Chinese J Tubercul Respir Dis 43(3):219\u2013222. https:\/\/doi.org\/10.3760\/cma.j.issn.1001-0939.2020.03.016","journal-title":"Chinese J Tubercul Respir Dis"},{"issue":"6","key":"2523_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","volume":"25","author":"AJ Turner","year":"2004","unstructured":"Turner AJ, Hiscox JA, Hooper NM (2004) ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 25(6):291\u2013294. https:\/\/doi.org\/10.1016\/j.tips.2004.04.001","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"2523_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s11739-020-02364-6","volume":"15","author":"A Albini","year":"2020","unstructured":"Albini A, Di Guardo G, Noonan DM, Lombardo M (2020) The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med 15(5):759\u2013766. https:\/\/doi.org\/10.1007\/s11739-020-02364-6","journal-title":"Intern Emerg Med"},{"key":"2523_CR12","doi-asserted-by":"publisher","unstructured":"Li LQ, Huang T (2020) COVID-19 patients\u2019 clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 92 (6):577\u2013583. https:\/\/doi.org\/10.1002\/jmv.25757","DOI":"10.1002\/jmv.25757"},{"issue":"3","key":"2523_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s00059-020-04909-z","volume":"45","author":"C Chen","year":"2020","unstructured":"Chen C, Zhou Y, Wang DW (2020) SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz 45(3):230\u2013232. https:\/\/doi.org\/10.1007\/s00059-020-04909-z","journal-title":"Herz"},{"issue":"2","key":"2523_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5049\/ebp.2013.11.2.41","volume":"11","author":"JY Moon","year":"2013","unstructured":"Moon JY (2013) Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension. Elect Blood Press E BP 11(2):41\u201345. https:\/\/doi.org\/10.5049\/ebp.2013.11.2.41","journal-title":"Elect Blood Press E BP"},{"key":"2523_CR15","unstructured":"World Health Organization (2020) Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organization. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200921-weekly-epi-update-6.pdf?sfvrsn=d9cf9496_6. Accessed 4 April 2020"},{"key":"2523_CR16","first-page":"246","volume":"205","author":"H Riazi","year":"2014","unstructured":"Riazi H, Jafarpour M, Bitaraf E (2014) Towards National eHealth Implementation\u2013a comparative study on WHO\/ITU National eHealth Strategy Toolkit in Iran. Stud Health Technol Informat 205:246\u2013250","journal-title":"Stud Health Technol Informat"},{"key":"2523_CR17","unstructured":"Iranian national scientific committee of COVID-19 managment (2020) Iraninan national guideline for diagnosis and treatment of COVID-19 in outpatient and inpatient settings No.5. https:\/\/firoozgar.iums.ac.ir\/files\/baharestan\/files\/n5.pdf. Accessed 18 Mar 2020"},{"issue":"4","key":"2523_CR18","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/s2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8(4):e21. https:\/\/doi.org\/10.1016\/s2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"issue":"5","key":"2523_CR19","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1096\/fj.202000782","volume":"34","author":"T Yan","year":"2020","unstructured":"Yan T, Xiao R, Lin G (2020) Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: a double-edged sword? FASEB J Off Publ Feder Am Soc Exp Biol 34(5):6017\u20136026. https:\/\/doi.org\/10.1096\/fj.202000782","journal-title":"FASEB J Off Publ Feder Am Soc Exp Biol"},{"issue":"8","key":"2523_CR20","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11(8):875\u2013879. https:\/\/doi.org\/10.1038\/nm1267","journal-title":"Nat Med"},{"issue":"18","key":"2523_CR21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.2020.4812","volume":"323","author":"AB Patel","year":"2020","unstructured":"Patel AB, Verma A (2020) COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence? JAMA 323(18):1769\u20131770. https:\/\/doi.org\/10.1001\/jama.2020.4812","journal-title":"JAMA"},{"issue":"1","key":"2523_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40635-015-0044-3","volume":"3","author":"V Zambelli","year":"2015","unstructured":"Zambelli V, Bellani G, Borsa R, Pozzi F, Grassi A, Scanziani M, Castiglioni V, Masson S, Decio A, Laffey JG, Latini R, Pesenti A (2015) Angiotensin-(1\u20137) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental acute respiratory distress syndrome. Intensive Care Med Exp 3(1):44. https:\/\/doi.org\/10.1186\/s40635-015-0044-3","journal-title":"Intensive Care Med Exp"},{"issue":"45","key":"2523_CR23","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1021\/bi035268s","volume":"42","author":"JL Guy","year":"2003","unstructured":"Guy JL, Jackson RM, Acharya KR, Sturrock ED, Hooper NM, Turner AJ (2003) Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 42(45):13185\u201313192. https:\/\/doi.org\/10.1021\/bi035268s","journal-title":"Biochemistry"},{"issue":"Pt 1","key":"2523_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/bj20040634","volume":"383","author":"GI Rice","year":"2004","unstructured":"Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383(Pt 1):45\u201351. https:\/\/doi.org\/10.1042\/bj20040634","journal-title":"Biochem J"},{"issue":"20","key":"2523_CR25","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/circulationaha.104.510461","volume":"111","author":"CM Ferrario","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Tallant EA, Diz DI, Gallagher PE (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111(20):2605\u20132610. https:\/\/doi.org\/10.1161\/circulationaha.104.510461","journal-title":"Circulation"},{"issue":"4","key":"2523_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.dsx.2020.03.016","volume":"14","author":"AK Singh","year":"2020","unstructured":"Singh AK, Gupta R, Misra A (2020) Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diab Metab Synd 14(4):283\u2013287. https:\/\/doi.org\/10.1016\/j.dsx.2020.03.016","journal-title":"Diab Metab Synd"},{"key":"2523_CR27","doi-asserted-by":"publisher","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H, Liu L, Zhang G (2020) Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9(1):757\u2013760. https:\/\/doi.org\/10.1080\/22221751.2020.1746200","DOI":"10.1080\/22221751.2020.1746200"},{"issue":"1","key":"2523_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/fjc.0000000000000156","volume":"65","author":"Y Wang","year":"2015","unstructured":"Wang Y, Moreira Mda C, Heringer-Walther S, Schultheiss HP, Siems WE, Wessel N, Walther T (2015) Beta blockers prevent correlation of plasma ACE2 activity with echocardiographic parameters in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 65(1):8\u201312. https:\/\/doi.org\/10.1097\/fjc.0000000000000156","journal-title":"J Cardiovasc Pharmacol"},{"key":"2523_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2261-14-148","volume":"14","author":"G Hao","year":"2014","unstructured":"Hao G, Wang Z, Guo R, Chen Z, Wang X, Zhang L, Li W (2014) Effects of ACEI\/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies. BMC Cardiovasc Disord 14:148. https:\/\/doi.org\/10.1186\/1471-2261-14-148","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"2523_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s00467-004-1554-5","volume":"19","author":"KF Hilgers","year":"2004","unstructured":"Hilgers KF, D\u00f6tsch J, Rascher W, Mann JF (2004) Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediat Nephrol (Berlin Ger) 19(9):956\u2013961. https:\/\/doi.org\/10.1007\/s00467-004-1554-5","journal-title":"Pediat Nephrol (Berlin Ger)"},{"issue":"1","key":"2523_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/hypertensionaha.120.15143","volume":"76","author":"G Yang","year":"2020","unstructured":"Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, Cai J, Yang R, Han J, Huang Y, He S (2020) Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: a single-center retrospective study. Hypertens (Dallas, Tex 1979) 76(1):51\u201358. https:\/\/doi.org\/10.1161\/hypertensionaha.120.15143","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"12","key":"2523_CR32","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/circresaha.120.317134","volume":"126","author":"P Zhang","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, Liu YM, Zhao YC, Huang X, Lin L, Xia M, Chen MM, Cheng X, Zhang X, Guo D, Peng Y, Ji YX, Chen J, She ZG, Wang Y, Xu Q, Tan R, Wang H, Lin J, Luo P, Fu S, Cai H, Ye P, Xiao B, Mao W, Liu L, Yan Y, Liu M, Chen M, Zhang XJ, Wang X, Touyz RM, Xia J, Zhang BH, Huang X, Yuan Y, Loomba R, Liu PP, Li H (2020) Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 126(12):1671\u20131681. https:\/\/doi.org\/10.1161\/circresaha.120.317134","journal-title":"Circ Res"},{"key":"2523_CR33","doi-asserted-by":"publisher","unstructured":"Sousa GJB, Garces TS (2020) Mortality and survival of COVID-19. Epidemiol Infect 148:e123. https:\/\/doi.org\/10.1017\/s0950268820001405","DOI":"10.1017\/s0950268820001405"},{"key":"2523_CR34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC (2020) Remdesivir for the treatment of Covid-19. Prelim Rep. https:\/\/doi.org\/10.1056\/NEJMoa2007764","journal-title":"Prelim Rep"},{"key":"2523_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.06.006","author":"CC Price","year":"2020","unstructured":"Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, McManus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M (2020) Tocilizumab treatment for cytokine release syndrome in hospitalized COVID-19 patients: survival and clinical outcomes. Chest. https:\/\/doi.org\/10.1016\/j.chest.2020.06.006","journal-title":"Chest"},{"key":"2523_CR36","unstructured":"Institute for health Metrics and Evaluation (IHME) (2015) global burden of diseases compare, Seattle, WA: IHME,University of Washington. https:\/\/vizhub.healthdata.org\/gbd-compare"},{"issue":"18","key":"2523_CR37","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.2020.4683","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323(18):1775\u20131776. https:\/\/doi.org\/10.1001\/jama.2020.4683","journal-title":"JAMA"},{"issue":"6","key":"2523_CR38","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11255-020-02451-9","volume":"52","author":"BM Henry","year":"2020","unstructured":"Henry BM, Lippi G (2020) Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection. Int Urol Nephrol 52(6):1193\u20131194. https:\/\/doi.org\/10.1007\/s11255-020-02451-9","journal-title":"Int Urol Nephrol"},{"key":"2523_CR39","doi-asserted-by":"publisher","first-page":"104371","DOI":"10.1016\/j.jcv.2020.104371","volume":"127","author":"Y Hu","year":"2020","unstructured":"Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, Wu Y, Sun L, Xu Y (2020) Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol Off Publi Pan Am Soc Clin Virol 127:104371. https:\/\/doi.org\/10.1016\/j.jcv.2020.104371","journal-title":"J Clin Virol Off Publi Pan Am Soc Clin Virol"},{"issue":"10229","key":"2523_CR40","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/s0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (Lond Engl) 395(10229):1054\u20131062. https:\/\/doi.org\/10.1016\/s0140-6736(20)30566-3","journal-title":"Lancet (Lond Engl)"},{"issue":"12","key":"2523_CR41","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.3346\/jkms.2020.35.e132","volume":"35","author":"Analysis on 54 mortality cases of coronavirus disease","year":"2019","unstructured":"Analysis on 54 mortality cases of coronavirus disease (2019) in the Republic of Korea from January 19 to March 10, 2020 (2020). J Korean Med Sci 35(12):e132. https:\/\/doi.org\/10.3346\/jkms.2020.35.e132","journal-title":"J Korean Med Sci"},{"issue":"5","key":"2523_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11739-020-02365-5","volume":"15","author":"R Sarzani","year":"2020","unstructured":"Sarzani R, Giulietti F, Di Pentima C, Filipponi A, Spannella F (2020) Antagonizing the renin-angiotensin-aldosterone system in the era of COVID-19. Intern Emerg Med 15(5):885\u2013887. https:\/\/doi.org\/10.1007\/s11739-020-02365-5","journal-title":"Intern Emerg Med"},{"issue":"4","key":"2523_CR43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P, Hagelkr\u00fcys A, Wimmer RA, Stahl M, Leopoldi A, Garreta E, Hurtado Del Pozo C, Prosper F, Romero JP, Wirnsberger G, Zhang H, Slutsky AS, Conder R, Montserrat N, Mirazimi A, Penninger JM (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181(4):905-913.e907. https:\/\/doi.org\/10.1016\/j.cell.2020.04.004","journal-title":"Cell"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-020-02523-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02523-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:47:04Z","timestamp":1634773624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-020-02523-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2523"],"URL":"https:\/\/doi.org\/10.1007\/s11739-020-02523-9","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study has been confirmed and granted by IRB of Iran University of Medical Sciences, Tehran, Iran with this number 99-1-39-17695. Ethics committee has also confirmed the research proposal by this code: IR.IUMS.REC.1399.200.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"All cases has signed an informed consent to use their data for research purposes at the registration time in each hospital.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}